There is 1 paper on retinal arteriolar wall-to-lumen ratio in aging research: 1 trial in people.
1 paper studies it3 findings
See all 1 papers on retinal arteriolar wall-to-lumen ratio
- Human trial1
Interventions
1Antihypertensive agents
no changein humans1downin humans1
1 study
Antihypertensive agents
no changein humans1downin humans1
Antihypertensive agents were not clearly linked with retinal arteriolar wall-to-lumen ratio in humans (multivariate analysis across drug regimens).
“In multivariate analysis, hypertension drug regimen was not an independent predictor of any retinal anatomical indices.”
Humansmultivariate analysis across drug regimensretinan = 1,000
Journal of hypertension
Antihypertensive agents are linked with lower retinal arteriolar wall-to-lumen ratio in humans (short-term drug-induced blood pressure drop (-29.3 ± 17.3/-14.4 ± 10.0 mmHg)) (-6.0 ± 8.0%).
“Short-term blood pressure drop (-29.3 ± 17.3/-14.4 ± 10.0 mmHg) induced a WLR decrease (-6.0 ± 8.0%) because of lumen dilatation (+4.4 ± 5.9%) without wall thickness changes.”
Humansshort-term drug-induced blood pressure drop (-29.3 ± 17.3/-14.4 ± 10.0 mmHg)retina
Journal of hypertension
Upstream
1Blood pressure
upin humans1
1 study
Blood pressure
upin humans1
Blood pressure is linked with higher retinal arteriolar wall-to-lumen ratio in humans.
“Blood pressure and age both independently increased WLR by thickening arterial wall.”
Humansretinan = 1,000
Journal of hypertension